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Abstract Depression is common in individuals with mul-
tiple sclerosis (MS). While psychotherapy is an effective
treatment for depression, not all individuals beneﬁt. We
examined whether baseline social support might differen-
tially affect treatment outcome in 127 participants with MS
and depression randomized to either Telephone-adminis-
teredCognitive-BehavioralTherapy(T-CBT)orTelephone-
administered Emotion-Focused Therapy (T-EFT). We
predicted that those with low social support would improve
more in T-EFT, since this approach emphasizes the thera-
peutic relationship, while participants with strong social
networks and presumably more emotional resources might
farebetterinthemorestructuredanddemandingT-CBT.We
found that both level of received support and satisfaction
with that support at baseline did moderate treatment out-
come. Individuals with high social support showed a greater
reductionindepressivesymptomsintheT-CBTaspredicted,
but participants with low social support showed a similar
reduction in both treatments. This suggests that for partici-
pantswithhighsocialsupport,CBTmaybeamorebeneﬁcial
treatment for depression compared with EFT.
Keywords Social support  Depression  Multiple
sclerosis  Cognitive Behavioral Therapy  Emotion-
Focused Therapy  Treatment outcome
Multiple sclerosis (MS) is a chronic and disabling auto-
immune disease of the central nervous system. The disease
can produce a wide variety of symptoms, including im-
paired motor function or feeling in limbs, debilitating fa-
tigue, pain, loss of bowel or bladder control, sexual
dysfunction, blindness due to optic neuritis, impaired
cognitive functioning and emotional symptoms (Goodkin
1992; Mohr and Cox 2001). Depression is common—
individuals with MS have a lifetime risk of major depres-
sive disorder of over 50% (Patten et al. 2003; Sadovnick
et al. 1996; Schubert and Foliart 1993)—and depression is
likely both a primary symptom of MS and secondary to the
unpredictability and impairment of the disease. Depression
not only exacerbates functional impairment in patients
(Mohr et al. 2007), there is also evidence that it also in-
creases inﬂammatory processes in MS (Gold and Irwin
2006; Mohr et al. 2001a, b).
Both psychotherapy and antidepressant medications
have been shown to be effective in reducing depression in
patients with MS (Foley et al. 1987; Mohr et al. 1999,
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DOI 10.1007/s10865-009-9235-22000b). One issue MS patients face, however, is difﬁculty
in accessing mental health care, particularly psychother-
apy. Like many other people living with chronic illness,
MS patients face fatigue and mobility issues that can make
it difﬁcult for them to physically get to regular appoint-
ments. Telephone therapy may help overcome some of the
barriers to direct care that people with chronic medical
conditions often face (Mohr et al. 2006). Telephone ther-
apy has been found to be an effective modality for deliv-
ering depression treatment in several studies (Miller and
Weissman 2002; Mohr et al. 2000a, 2005; Sandgren and
McCaul 2003; Simon et al. 2004). In fact, a recent study
found that telephone therapy was as effective as face-to-
face therapy in the treatment of Obsessive Compulsive
Disorder (Lovell et al. 2006).
But while the telephone administration of psychotherapy
for depression may overcome certain barriers to care, there
remains the vexing problem that even the most effective
depression treatments (no matter how they are delivered)
fail to help a large percentage of the patients in randomized
control trials—25–50% do not show improvement at post-
treatment, and among those who do improve, many relapse
by the 1–2 year follow-ups (DeRubeis et al. 2005; Westen
and Morrison 2001). This may partly be due to the fact that
different patients may fare better in one type of treatment
over another, depending on individual characteristics and
factors. The key to improving outcome, then, is to better
match patients to particular treatments. In searching for
variables that may differentially affect outcome in one
depression approach versus another, social support stands
out as a likely treatment outcome moderator.
There is a well-documented literature establishing a
relationship between social support and depression. In
naturalistic studies it has been found that lower levels of
social support are associated with higher levels of depres-
sion (for a review, see Bagby et al. 2002; Brugha et al.
1987; Grant et al. 2006). Others have described the lack of
a social support structure as an important vulnerability
factor for depression in both healthy (Bosworth et al. 2002;
Bromberger et al. 1994; Ezquiaga et al. 1998; Vanderhorst
and McLaren 2005) and medically ill populations (Liu
et al. 2006; Revenson et al. 1991). Some studies also
suggest that social support positively predicts better treat-
ment outcome in depression. In several controlled trials for
inpatient treatment of depression, higher levels of social
support predicted improvement (George et al. 1989; Keit-
ner et al. 1997; Nasser and Overholser 2005; Szadoczky
et al. 2004). Others have reported similar results in out-
patients who received either psychopharmacological
interventions or psychotherapy for depression (Ezquiaga
et al. 1998; Lyness et al. 2006; Oxman and Hull 2001).
However, studies do not show a uniformly positive
relationship between social support and improvement in
depression in treatment outcome research (Beekman et al.
1997; Paykel et al. 1996), suggesting that the relationship
of social support to outcome may vary with the treatment
approach. In a study by Helgeson and colleagues, indi-
viduals with high levels of social support fared less well in
a peer support group than did those who reported low
levels of social support at baseline (Helgeson et al. 2000).
One explanation for this ﬁnding is that those with low
social support beneﬁted more from group therapy than their
high social support cohorts because the treatment provides
what these individuals lack—group members’ empathy and
support. In the realm of individual therapy, some theoret-
ical approaches place a heavy emphasis on the therapeutic
relationship, and it is possible that individuals with low
social support might beneﬁt more from the direct support
provided by these depression treatments compared with
more practical, skill-building approaches such as cognitive-
behavioral therapy (CBT). Those with high social support,
on the other hand, may have more emotional resources to
take on the challenging tasks of CBT including doing
homework, testing out new behaviors, and developing new
skills.
In the current study, we tested whether social support
moderates outcome in two telephone treatments targeting
depressive symptoms in patients with MS: Telephone-
administered Cognitive-Behavioral Therapy (T-CBT) and
Telephone-administered Emotion-Focused Therapy (T-EFT).
T-EFT is based on Greenberg’s Process-Experiential ther-
apy manual (Greenberg et al. 1993), and is a humanistic
approach that emphasizes using the therapeutic bond to
help patients express and process emotional material.
T-EFT also includes speciﬁc interventions that target self-
criticism and dependence, which can interfere with rela-
tionships and social support. While the therapeutic alliance
between the therapist and patient is an important factor in
T-CBT as well (Beckner et al. 2007), T-CBT is highly
structured and session time is focused on teaching com-
municationandproblem-solvingskills,fatiguemanagement
planning, and cognitive restructuring of depressogenic
automatic thoughts and beliefs. We predicted that MS
patients with low levels of received social support and low
satisfaction with that support at baseline would improve
more in the T-EFT condition, while patients who score high
on these baseline social support variables would do pref-
erentially well in the T-CBT condition. We looked at both
level of received social support and satisfaction with that
support separately, given that these constructs are concep-
tually unique (i.e., one may have large social network but
feel unhappy with the quality of that support). Several
studies have also found that satisfaction with support
(quality) may be a better predictor of depression outcome
than quantity of support received (Beedie and Kennedy
2002; Rintala et al. 1992).
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This study is a secondary analysis from a randomized
clinical trial examining telephone-administered psycho-
therapy treatments for depression among patients with
multiple sclerosis (please see Mohr et al. 2005 for addi-
tional details regarding methods and primary treatment
outcomes).
Participants
Participants were recruited to participate in a telephone-
administered depression treatment by letter to Kaiser
Permanente Medical Care Group of Northern California
members and advertising and outreach through regional
chapters of the National Multiple Sclerosis Society. All
potential participants were verbally consented over the
telephone prior to a screening interview. If after the initial
screening process participants were still eligible to partic-
ipate, they were mailed a written consent before being
more thoroughly assessed on all inclusion and exclusion
criteria. The consent process was approved by the Human
Subjects Review Committees of both the University of
California at San Francisco and Kaiser Permanente. Par-
ticipants were paid $10.00 to $50.00 per assessment,
depending on the length of the assessment.
Inclusion criteria included: (1) a neurologist conﬁrmed
diagnosis of MS, (2) functional impairment resulting in
limitations in activity as measured by a score of at least 3
(out of a total of 6) on one or more functional areas assessed
by the Guy’s Neurological Disability Scale (Sharrack and
Hughes 1999), (3) a score of at least 16 on the Beck
Depression Inventory-II (BDI-II, Beck et al. 1996) and at
least 14 on the Hamilton Depression Rating Scale (HAM-D,
Hamilton 1960), (4) ability to speak and read English, (5) at
least age 18. Participants were excluded if they (1) met
criteria for dementia using a standard battery for MS (Mohr
et al. 2001b), (2) were currently in psychotherapy, (3)
showed severe psychopathology including psychosis, cur-
rent substance abuse, plan and intent to commit suicide, (4)
were currently experiencing an MS exacerbation, (5)
reportedphysical deﬁcitsthat would prevent participationin
treatment or assessment, including inability to speak, read,
or write, and (6) use of medications, other than antidepres-
sants, that impact mood (e.g. steroidal anti-inﬂammatories).
Use of antidepressant medications was not exclusionary.
Among the 748 participants who completed a telephone
screen, 223 were eligible for and agreed to a complete
eligibility assessment. Of those, 150 were found to be
eligible for randomization, though 23 (15.3%) refused to be
randomized. Therefore, 127 participants were randomized:
62 were assigned to the T-CBT condition and 65 were
assigned to the T-EFT condition. There were 3 participants
in the T-CBT condition and four in the T-EFT condition
who dropped out of treatment; of those, 2 in the T-CBT
condition and 3 in the T-EFT condition completed the
remaining assessments. Two participants discontinued
assessments once treatment was completed in the T-CBT
condition, and 3 in the T-EFT condition.
The ﬁnal intent-to-treatsample of127 was largelyfemale
(77%) and Caucasian (90%), with 5% African American,
1.5% Hispanic, and about 1% Asian. The gender and eth-
nicity of the sample reﬂects the epidemiology of multiple
sclerosis, which largely afﬂicts women and Caucasians. The
mean age of participants was 47.96 (SD = 10.10). The
sample was educated (M = 15.36 years, SD = 2.56), with
26% employed, 11% unemployed, over half on disability
(54%), and 9% indicating ‘‘other.’’ The monthly household
income was M = $3,825.69 (SD = $2,612.09). The
majority (78%) lived with a spouse or partner, and the mean
number of people in the household was between 2 and 3
(M = 2.54, SD = 1.32). Just over half of the sample was
taking medication for depression (55% in each group). The
two treatment groups did not differ signiﬁcantly on any of
thesemeasures(ps[0.41;seeTable 1fordemographicsby
group).
Treatments
T-CBT and T-EFT are manualized psychotherapy treat-
ments for depression. Both treatments were delivered over
16 weekly 50-min telephone sessions by licensed, doctoral-
level psychologists with 1–5 years of postdoctoral practice.
While CBT and EFT both include many ‘‘non-speciﬁc’’
characteristics of therapy (active listening by the therapist,
a supportive therapeutic relationship), each had their own
unique therapeutic interventions (see below). Adherence to
treatment was conﬁrmed (see section on clinicians below
for ﬁdelity measurement).
Telephone-administered Cognitive Behavioral Therapy
(T-CBT)
T-CBT is a structured, manualized approach based on
standard CBT for depression (Beck et al. 1979; Beck
1995). We have developed a participant workbook to guide
the treatment (Mohr et al. 2001a, 2000a). The manual in-
cluded ﬁve chapters that are used by all participants which
focused on teaching the participants methods to identify
and modify depressogenic thoughts, increase the number
pleasant activities in their life, enhance effective problem
solving, and manage interpersonal difﬁculties (through
improving communication skills and increasing social
support). There were also 11 optional modules for speciﬁc
problems such as fatigue management and sexual
J Behav Med (2010) 33:47–59 49
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identify areas they believe to be particularly problematic
from these 11 modules, and to focus on and apply the skills
learned in every day settings. The T-CBT manual did not
include interventions speciﬁc to T-EFT (below), such as
having patients focus on deepening their emotional expe-
rience by forming an image of the emotion and describing
it’s shape, color, and so on.
Telephone-administered Emotion Focused Therapy
(T-EFT)
T-EFT is a manualized process-experiential therapy
developed by Greenberg and adapted for this study
(Greenberg et al. 1993). The approach was chosen because
of its emphasis on non-CBT components, including a pri-
mary focus on empathic attunement and the facilitation
of communicating emotional experience in the moment.
T-EFT emphasizes the creation of a genuine, supportive
and validating therapeutic relationship as the necessary
condition for using process interventions aimed at carefully
exploring emotional experience. Through careful attune-
ment to affective material in the moment, T-EFT therapists
help clients work though emotional difﬁculties presumed to
underlie depression. In the current study, T-EFT therapists
were instructed to avoid interventions that focused on
modifying cognitions, behaviors, or skill attainment, to
minimize the overlap between the two approaches. Some of
theprocessesusedinGreenberg’soriginaltreatment,suchas
empty chair and two-chair work, were impossible given that
the therapy was conducted over the phone. T-EFT was also
chosenbecauseitsuccessfullycontrolledforallnon-speciﬁc
factors associated with T-CBT, including the therapeutic
relationship and the use of a manualized treatment.
Clinicians and treatment ﬁdelity
A total of 9 therapists were used. The 5 T-CBT therapists
were trained in the model and reported that they primarily
used CBT in their practices. The 4 T-EFT therapists
expressed a strong belief that change in therapy is primarily
driven by the therapeutic relationship. In addition, all
T-EFT therapists denied using CBT techniques or using
skill-based training in their practices. Therapist adherence
to the model was rated by blinded research assistants with 2
days of training on rating adherence. Two sessions from
each therapist were randomly selected for rating, using a
modiﬁed version of the Cognitive Therapy Scale (Vallis
et al. 1986) that included all original items as well as some
speciﬁc to T-EFT therapeutic procedures. T-CBT therapists
were rated as performing signiﬁcantly more cognitive-
behavioral interventions on the summary score (t(240) =
-49.36, p = 0.001) and overall rating of CBT perfor-
mance (t(240) = 54.40, p = 0.01). T-EFT therapists were
Table 1 Demographics by
condition
Note: T-CBT Telephone-
administered Cognitive
Behavioral Therapy, T-EFT
Telephone-administered
Emotion Focused Therapy
Measure T-EFT (n = 65) CBT (n = 62) p-Value
Mean (SD) or n (%) Mean (SD) or n (%)
Mean age 47.35 (10.10) 48.60 (9.61) 0.47
Education (years) 15.46 (2.57) 15.26 (2.57) 0.66
Gender (female) 51 (78%) 47 (76%) 0.72
Ethnicity 0.42
Caucasian 56 (86%) 58 (93.5%)
Asian 1 (1.5%) 0 (0%)
Hispanic 1 (1.5%) 1 (1.5%)
African American 3 (5%) 3 (5%)
Other 4 (6%) 0 (0%)
Employment status 0.77
Employed 17 (26%) 16 (26%)
Unemployed 7 (11%) 7 (11%)
Disability 37 (57%) 32 (52%)
Other 4 (6%) 7 (11%)
Marital status 0.45
Single 10 (15%) 5 (8%)
Separated/Divorced 14 (22%) 14 (22.5%)
Widowed 3 (5%) 3 (5%)
Married/Living with Partner 38 (58%) 40 (64.5%)
Number in household (including self) 2.52 2.56 0.84
Total monthly household income 4,016 (2,679) 3,621 (2,545) 0.41
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evoking emotional expression (t(240) = 33.67, p = 0.01)
and fostering participants’ awareness of internal experience
(t(240) = 4.03, p = 0.01).
Assessments
Outcome measures were assessed at baseline and week 16
(post-treatment). Social support was measured at baseline.
Self-report measures were mailed to participants along
with stamped addressed return envelopes. All interview
assessments were conducted over the telephone by trained
and blinded clinical evaluators. Participants were instructed
to complete all self-report measures on the day of the
interview; if the measures were not completed at the onset
of the interview, the assessment was rescheduled. In order
to maintain the blind, all assessment interviews were pre-
ceded by a request not to discuss any aspect of therapy. In
addition, all interviews were audiotaped and the clinical
evaluators met monthly to co-rate an assessment tape in
order to calibrate and maintain reliabilities. Eight evalua-
tors were used during the study.
Social support
Social support was assessed using the UCLA-Social Sup-
port Inventory (UCLA, Dunkel-Schetter et al. 1986). This
measure is designed to be ﬂexible in order to accommodate
different research questions. We looked at items tapping
two aspects of social support: level of received support and
satisfaction with that support. Level of received support
included 5 items such as ‘‘When you were stressed, how
often did you receive encouragement and reassurance?’’
and ‘‘How often did you feel loved and cared for?’’ The
participant then rated on a 5-point scale the degree to
which this support was provided by four different sources
of support: partner/family members, friends, medical pro-
viders, and organizations/groups. Following each of these
questions, we asked how satisﬁed the participants felt with
that support (5 satisfaction questions). Both level of re-
ceived support and satisfaction with support had good
reliability (level of received support, a = 0.87; satisfaction
with that support, a = 0.84).
Depression severity
Depressive symptoms were assessed at baseline and post-
treatment using the Beck Depression Inventory-II (BDI-II,
Beck et al. 1996) and the Hamilton Depression Rating
Scale (HAM-D, Hamilton 1960). The BDI-II is a 21-item
self-report measure of depression, which is both widely
used and reliable. In addition, the BDI-II is not confounded
with MS symptom severity (Aikens et al. 1999; Moran and
Mohr 2005). The HAM-D is a 17-item semi-structured
interview that was adapted for use over the telephone (Potts
et al. 1990). Raters were trained by listening to previous
tapes and engaging in mock interviews. Reliability checks
were conducted throughout the study duration; using
interclass correlations, reliabilities averaged 0.89 (range,
0.75–0.97).
MS-related disability
MS-related disability was assessed as part of the inclusion
criteria in the study, and was determined using The Guy’s
Neurological Disability Scale (Sharrack and Hughes 1999),
whichisastructuredinterviewthatassesses11basicareasof
function (eg, limb function and vision). It produces a single
score that is highly related (r = 0.81) to objective measures
of functional impairment based on neurologist examination.
We dropped the item assessing mood because it is con-
foundedwith our outcome measures. Each item rates a basic
area of functioning from 1 (no symptoms) to 5 (a speciﬁc
criterion reﬂecting extremely severe impairment). A 3 on
any item reﬂects the point at which the functional impair-
ment interferes with normal daily functioning.
Results
Baseline measures
Baseline variables were analyzed using the student t-test for
continuous variables and chi square analysis for categorical
variables to conﬁrm integrity of randomization. None of the
baseline demographic variables differed between treatment
groups (see Table 1). We also conﬁrmed that the treatment
groups did not differ at baseline on depression severity.
Means and standard deviations on the BDI-II for the T-EFT
group and T-CBT groups respectively were: M = 28.32,
SD = 7.91; M = 27.00, SD = 7.78; p = 0.34. Means for
the two groups on the Hamilton were: M = 21.66,
SD = 3.53; M = 21.35, SD = 3.90; p = 0.65. In addition,
no differences between treatment groups were found for the
baseline social support measures: level of received support
(M = 49.60, SD = 12.56; M = 48.32, SD = 11.40;
p = 0.55) and satisfaction with support (M = 21.64,
SD = 5.34; M = 20.73, SD = 5.89; p = 0.36).
Main effects and moderator analyses
Hierarchical multiple linear regression techniques were
used to examine the interaction effect between baseline
social support and treatment condition on depression out-
comes. Because demographics and disease related vari-
ables are not speciﬁcally relevant to the question, are
J Behav Med (2010) 33:47–59 51
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known not to affect these outcomes (Mohr et al. 2005),
they were not included in the analyses. This reduces the
risk of spurious ﬁndings related to overﬁtting regression
models (Babyak 2004).
Each social support measure (level of received support
and satisfaction with support) was tested separately. Base-
line depression was entered ﬁrst to control for depression
severity at the start of treatment, given that it was a signiﬁ-
cant predictor of end of treatment depression in every model
(ps B 0.01). Baseline social support was entered next, fol-
lowedbytreatmentassignment,andﬁnallythecross-product
of treatment condition and social support at baseline. The
direction of the interaction in signiﬁcant models was ex-
plored using scatter plots of the unstandardized predicted
value from the interaction model and the social support
variable at baseline. Examination of the moderation effect
wasalsodonewithineachtreatmentconditionforeachsocial
support outcome found to have a signiﬁcant moderation
effect with treatment. The main effect model was tested
separately within the T-EFT and T-CBT conditions to
determine the relationship between baseline social support
and depression outcome within each treatment condition,
controlling for baseline depression level.
Results of the analyses are displayed in Tables 2 and 3.
There were no signiﬁcant main effects for either baseline
level of received social support or satisfaction with support
on the BDI-II or the HAM-D at end of treatment
(ps C 0.13). However, the two social support variables did
appear to moderate treatment outcome for depression.
First, a signiﬁcant interaction between level of received
support and treatment was found when predicting end
of treatment residualized BDI-II and HAM-D scores
(ps\0.03). The meaning of these interactions was
examined using separate regressions within each treatment
condition, as displayed in Fig. 1. For participants assigned
to the T-CBT condition, higher baseline received support
was associated with lower residualized end-of-treatment
BDI-II and HAM-D scores (b =- 0.33 and b =- 0.35,
respectively, ps B 0.01). This relationship was not signif-
icant for those assigned to T-EFT (ps C 0.43). Next, a
signiﬁcant interaction was observed for satisfaction with
support and treatment when predicting end of treatment
residualized BDI-II and HAM-D scores (ps B 0.01).
Again looking within each treatment (see Fig. 2), baseline
satisfaction with support signiﬁcantly predicted both end
of treatment BDI-II and HAM-D scores within the
T-CBT condition (b =- 0.42 and b =- 0.44, respec-
tively, ps B 0.01), but not within the T-EFT condition
(ps C 0.33).
1
To further examine the moderation effect, the two
social support variables were subdivided into binary cat-
egorical variables using the median social support value
as the cut-point. This allowed us to directly compare
treatment outcome for individuals who entered the study
with either low or high social support using a t-test.
Table 2 Hierarchical regression analysis for main effect of social
support scales on BDI-II measure of depression and interaction model
with treatment
Outcome: BDI-II at end
of treatment
Models with interaction
Beta R
2 change p value
Level of support received
BDI-II at baseline 0.52 0.17 0.01
Support received at baseline 0.17 0.01 0.25
Treatment condition 14.2 0.02 0.14
Support received 9 treatment -0.65 0.06 0.01
Total Adjusted R
2 0.22 0.01
Satisfaction with support
BDI-II at baseline 0.45 0.19 0.01
Satisfaction at baseline 0.23 0.02 0.14
Treatment condition 18.19 0.02 0.16
Satisfaction 9 treatment -0.98 0.07 0.01
Total R
2 0.26 0.01
Table 3 Hierarchical regression analysis for main effect of social
support scales on HAM-D measure of depression and interaction
model with treatment
Outcome: HAM-D end
of treatment
Models with interaction
Beta R
2 change P value
Level of support received
HAM-D at baseline 0.40 0.067 0.01
Support received at baseline 0.05 0.012 0.21
Treatment condition 6.49 0.045 0.02
Support received 9 treatment -0.30 0.034 0.03
Total adjusted R
2 0.129 0.01
Satisfaction with support
HAM-D at baseline 0.39 0.068 0.01
Satisfaction at baseline 0.12 0.019 0.13
Treatment condition 8.69 0.046 0.02
Satisfaction 9 treatment -0.54 0.056 0.01
Total R
2 0.160 0.01
1 In our exploratory analyses, we also looked at items on our social
support measure that tap instrumental versus emotional support, to
Footnote 1 continued
determine whether type of support might moderate outcome differ-
ently. We obtained the same moderating and within-treatment group
ﬁndings using these support variables: participants with higher
instrumental or higher emotional support at baseline improved more
in the T-CBT group, while level of instrumental or emotional support
did not affect depression outcome in the T-EFT group.
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123Figures 3 and 4 show the mean depression scores and
standard errors in the high and low social support groups
(received support and satisfaction, respectively) by treat-
ment assignment. Among participants who scored below
the median on the received support scale, t-tests showed
no difference between treatments for either the BDI-II or
the HAM-D (ps C 0.31). However, t-tests conducted with
participants who scored above the median on received
support showed that those in the T-CBT group had greater
reduction in depression on the HAM-D (p = 0.04); this
relationship only reached a trend level on the BDI-II
(p = 0.087). For satisfaction with support, the t-tests
conducted with those below the median again showed no
signiﬁcant differences between treatments in change
scores for the BDI-II or HAM-D (ps C 0.41). However,
those who fell above the median did signiﬁcantly better in
Fig. 1 Relationship between
level of received support at
baseline and post-treatment
depressive symptoms
(residualized BDI-II and
HAM-D scores) as a function
of treatment. Separate
regression analyses
demonstrated that level of
received social support
predicted depression scores
within the Telephone-
administered Cognitive
Behavioral Therapy (T-CBT)
condition, but not within the
Telephone-administered
Emotion Focused Therapy
(T-EFT) condition
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123the T-CBT compared with the T-EFT on both the BDI-II
and HAM-D (ps B 0.03).
Discussion
To our knowledge, this study is the ﬁrst to examine whether
two bona ﬁde depression treatments differentially impact
depressive symptoms depending on the participant’s base-
line level of social support. We found that both the level of
social support participants reported receiving at baseline, as
well as their satisfaction with that support, moderated
treatment outcome among participants with MS and
depression. Speciﬁcally, individuals with higher levels of
received support and satisfaction with their social support
network showed greater reductions in depressive symptoms
Fig. 2 Relationship between
satisfaction with support at
baseline and post-treatment
depressive symptoms
(residualized BDI-II and
HAM-D scores) as a function of
treatment. Separate regression
analyses demonstrated that
support satisfaction predicted
depression scores within the
Telephone-administered
Cognitive Behavioral Therapy
(T-CBT) condition, but not
within the Telephone-
administered Emotion Focused
Therapy (T-EFT) condition
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123when enrolled in T-CBT compared with T-EFT. Partici-
pants with low social support at baseline improved similarly
in both treatments. This suggests that depression outcomes
do vary depending on baseline levels of social support and
treatment type, but that the important differences are only
seen in participants with high social support. These results
have important implications for matching participants to
treatments. For participants with high social support, CBT
may be a more beneﬁcial treatment for depression than
emotion-focused therapy. These results need to be repli-
cated, however, given recent ﬁndings that challenge the
robustness of interaction ﬁndings (Risch et al. 2009).
While the data supported our prediction that those with
high social support would see greater reductions in
depression with a cognitive-behavioral approach compared
with an experiential emotion-focused approach, there are
several possible explanations for this ﬁnding. Our
hypothesis was based on the idea that individuals with a
strong social network do not need the supportive ‘‘ear’’ of a
therapist in the same way that those with little social sup-
port do. They already have empathetic people in their life;
what they need to do is make some behavioral changes to
break the depression cycle (i.e., challenge negative inter-
pretations, engage in pleasurable activities, etc.). We also
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123suspect that high social support may be a ‘‘marker’’ for
certain skills or traits that facilitate improvement in
T-CBT, such as greater openness to trying new behaviors,
or more cognitive resources for learning new skills.
Additional research is needed to investigate these or other
possible explanations.
In contrast, we expected that participants with lower
baseline levels of social support (both level of received and
satisfaction with that support) would improve more in the
T-EFT treatment. Because the T-EFT intervention focuses
speciﬁcally on the therapeutic relationship—encouraging
clients to express and explore emotional issues within the
context of this safe and empathetic bond—we expected that
this approach would ﬁll an important social support gap for
those who lack family and friends with whom they can talk
to. The data did not support this hypothesis: participants
low in social support improved similarly in both treatment
groups.
There are a number of ways to interpret this outcome. It
may be that while the T-CBT therapists are focused more on
education and skills training, they are also providing a sup-
portive bond within the therapeutic relationship. Indeed,
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123evidence suggests that the therapeutic alliance is as strong
between clients and therapists using a cognitive-behavioral
approach compared to therapists using various process-ori-
entedapproachesthatspeciﬁcallyemphasizethetherapeutic
bond (Beckner et al. 2007). An alternative interpretation is
that among participants with low social support, similar
levels of improvement resulted for different therapeutic
processes. For example, those who received T-EFT may
have responded positively to the focus on the therapy rela-
tionship, while those in the T-CBT may have beneﬁted from
the CBT skills training. No matter what the explanation,
however,itisclearthatforparticipantswhoenteredthestudy
with a weak social network, it didn’t matter which treatment
they received: both reduced depression similarly.
An important caveat is that that all of the participants
were managing a chronic, debilitating medical illness.
Social support may interact with depression in a unique
way within certain medical populations, like MS. While
short-term illness often elicits social support, chronic ill-
ness can exhaust people’s network and strain relations with
family and close friends, leading to isolation or less satis-
faction with one’s social support. Physical symptoms and
related disability can also make attending social activities
difﬁcult. Participants in this study all had at least
one symptom that impaired their daily functioning (i.e.,
mobility issues, fatigue, etc.) that could have impacted
social relationships. It is therefore difﬁcult to know whe-
ther the ﬁndings in this study would generalize to indi-
viduals in good health or without a disability.
It is also important to consider the fact that both treat-
ments in this study were delivered over the phone. While
the data indicates that both T-CBT and T-EFT are effective
in reducing depression (see Mohr et al. 2005), it is difﬁcult
to know whether the interaction of social support with the
treatments was affected by their mode of delivery. There is
evidence that good rapport was established and maintained
in therapy, and did not differ between conditions (Beckner
et al. 2007). However, non-verbal communication may be
essential to fully facilitate the emotional processing that is
the core of Emotion-Focused Therapy. It remains an
empirical question whether those with low social support
might indeed beneﬁt more from an experiential approach
emphasizing the therapeutic relationship if it was delivered
face-to-face.
In summary, if our ﬁndings are conﬁrmed in subsequent
research, it may be important in treating depression in
people with chronic illness that their baseline level of
social support is assessed prior to selecting a treatment
approach. Although our study suggests that individuals
who report low social support may do just as well in a
variety of treatments, this does not appear to be the case for
individuals with MS who entered treatment for depression
with a relatively strong social support network. Matching
these individuals with a CBT based treatment may signif-
icantly improve the likelihood of a positive outcome.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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